US 11,918,806 B2
Systems, methods and devices for peripheral neuromodulation of the leg
Serena HanYing Wong, Palo Alto, CA (US); Kathryn H. Rosenbluth, San Francisco, CA (US); Samuel Richard Hamner, San Francisco, CA (US); Peter Lin, San Jose, CA (US); and Benjamin Pless, Burlingame, CA (US)
Assigned to Cala Health, Inc., San Mateo, CA (US)
Filed by Cala Health, Inc., San Mateo, CA (US)
Filed on May 11, 2022, as Appl. No. 17/663,004.
Application 17/663,004 is a continuation of application No. 16/071,056, granted, now 11,344,722, previously published as PCT/US2017/014431, filed on Jan. 20, 2017.
Claims priority of provisional application 62/365,326, filed on Jul. 21, 2016.
Claims priority of provisional application 62/352,462, filed on Jun. 20, 2016.
Claims priority of provisional application 62/281,606, filed on Jan. 21, 2016.
Prior Publication US 2022/0266011 A1, Aug. 25, 2022
Int. Cl. A61N 1/04 (2006.01); A61N 1/36 (2006.01)
CPC A61N 1/36007 (2013.01) [A61N 1/0456 (2013.01); A61N 1/0484 (2013.01); A61N 1/36031 (2017.08)] 20 Claims
OG exemplary drawing
 
1. A wearable device for transcutaneous stimulation in response to leg restlessness, the device comprising:
a controller;
at least one biomedical sensor to measure restlessness of a leg;
a first peripheral nerve effector comprising at least one stimulation electrode configured to be positioned to transcutaneously modulate a first afferent nerve pathway;
a second peripheral nerve effector comprising at least one stimulation electrode configured to be positioned to transcutaneously modulate a peroneal nerve; and
wherein the controller comprises a processor and a memory and is arranged to cause the device to:
adjust one or more parameters of a first electrical stimulus and a second electrical stimulation based at least in part on information received from the at least one biomedical sensor; and
deliver the first electrical stimulus to the first afferent nerve pathway through the first peripheral nerve effector and deliver the second electrical stimulus to the peroneal nerve through the second peripheral nerve effector,
wherein the device is not configured for implantation within the patient.